Literature DB >> 8036720

Gene therapy for cancer.

K W Culver1, R M Blaese.   

Abstract

Initiation of clinical trials of gene therapies for cancer has been made possible by two major technological advances: the ability to clone genes that constitute the genetic basis of carcinogenesis or that have therapeutic potential, and the development of an increasing number of gene transfer methods. As a result, 30 experimental trials of gene therapy for the treatment of human cancer have been approved in the United States of America. Here, we discuss the current status of gene therapy for cancer together with future directions for its development.

Entities:  

Mesh：

Year:  1994        PMID： 8036720     DOI： 10.1016/0168-9525(94)90095-7

Source DB:  PubMed          Journal:  Trends Genet        ISSN： 0168-9525            Impact factor:   11.639


  14 in total

Review 1.  Imaging transgene expression with radionuclide imaging technologies.

Authors:  S S Gambhir; H R Herschman; S R Cherry; J R Barrio; N Satyamurthy; T Toyokuni; M E Phelps; S M Larson; J Balatoni; R Finn; M Sadelain; J Tjuvajev; R Blasberg
Journal:  Neoplasia       Date:  2000 Jan-Apr       Impact factor: 5.715

2.  Efficient c-kit receptor-targeted gene transfer to primary human CD34-selected hematopoietic stem cells.

Authors:  Q Zhong; P Oliver; W Huang; D Good; V La Russa; Z Zhang; J R Cork; R W Veith; C Theodossiou; J K Kolls; P Schwarzenberger
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

3.  The use of gating technology in bioengineering insulin-secreting cells from embryonic stem cells.

Authors:  Enrique Roche; Mark M Burcin; Sybille Esser; Manfred Rüdiger; Bernat Soria
Journal:  Cytotechnology       Date:  2003-03       Impact factor: 2.058

Review 4.  Prospects for human gene therapy.

Authors:  A Bout
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1996 Apr-Jun       Impact factor: 2.441

Review 5.  Current aspects of gene therapy: implications for vascular interventions.

Authors:  F Reifers; J Kreuzer
Journal:  J Mol Med (Berl)       Date:  1995-12       Impact factor: 4.599

Review 6.  Direct cell killing by suicide genes.

Authors:  L A Martin; N R Lemoine
Journal:  Cancer Metastasis Rev       Date:  1996-09       Impact factor: 9.264

7.  Diseases originate and terminate by genes: unraveling nonviral gene delivery.

Authors:  Rajan Swami; Indu Singh; Wahid Khan; Sistla Ramakrishna
Journal:  Drug Deliv Transl Res       Date:  2013-12       Impact factor: 4.617

Review 8.  Malignant mesothelioma: new insights into tumour biology and immunology as a basis for new treatment approaches.

Authors:  J W Upham; M J Garlepp; A W Musk; B W Robinson
Journal:  Thorax       Date:  1995-08       Impact factor: 9.139

Review 9.  Gene therapy of cancer.

Authors:  A Bank
Journal:  Med Oncol       Date:  1995-09       Impact factor: 3.064

10.  The Herbal Medicine Utrica Dioica Inhibits Proliferation of Colorectal Cancer Cell Line by Inducing Apoptosis and Arrest at the G2/M Phase.

Authors:  Ali Mohammadi; Behzad Mansoori; Mahyar Aghapour; Pooneh Chokhachi Baradaran; Neda Shajari; Sadaf Davudian; Shima Salehi; Behzad Baradaran
Journal:  J Gastrointest Cancer       Date:  2016-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.